Effects of tamoxifen on L-glutamate transporters of astrocytes

J Pharmacol Sci. 2008 Jun;107(2):226-30. doi: 10.1254/jphs.08039sc. Epub 2008 Jun 10.

Abstract

Tamoxifen (Tam) decreased the clearance of L-glutamate (L-Glu) by cultured astrocytes at 1 pM, 1 nM, and 1 microM, but became toxic at 10 microM. When L-Glu transporters were mostly inhibited by threo-beta-benzyloxyaspartate (TBOA) (1 mM) or D,L-threo-beta-hydroxyaspartate (THA) (1 mM), Tam (1 nM) did not change extracellular L-Glu concentration, confirming that Tam attenuates L-Glu transport through L-Glu transporters. ICI182,780, LY294002, and U0126 inhibited the effect of Tam dose-dependently, suggesting the involvement of estrogen receptors (ERs), the phosphatidylinositol 3-kinase (PI3K) cascade, and the mitogen-activated protein kinase (MAPK) cascade in the effect of Tam.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Transport System X-AG / physiology*
  • Animals
  • Aspartic Acid / pharmacology
  • Astrocytes / metabolism*
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Estrogen Antagonists / pharmacology*
  • Glutamic Acid / metabolism
  • MAP Kinase Signaling System
  • Phosphatidylinositol 3-Kinases / physiology
  • Rats
  • Rats, Wistar
  • Receptors, Estrogen / physiology
  • Tacrine / pharmacology
  • Tamoxifen / pharmacology*

Substances

  • Amino Acid Transport System X-AG
  • Estrogen Antagonists
  • Receptors, Estrogen
  • benzyloxyaspartate
  • Tamoxifen
  • Aspartic Acid
  • Glutamic Acid
  • Tacrine
  • Phosphatidylinositol 3-Kinases